Vaccines
DIFF Biotech Secures China Clinical Approval For First Domestic Nasal Spray Influenza Vaccine
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, ...
February 10, 2026 | News
Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104
Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...
February 09, 2026 | News
Samsung Biologics Partners With Coalition for Epidemic Preparedness Innovations To Boost Outbreak Ready Vaccine Manufacturing
The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organiz...
February 05, 2026 | News
SK bioscience Advances Early Clinical RSV Preventive Monoclonal Antibody Licensed From Gates Medical Research Institute
SK to advance novel early-clinical stage RSV preventive monoclonal antibody in-licensed from Gates Medical Research Institute Exclusive rights to commer...
February 05, 2026 | News
GHIT Fund Commits JPY 1.39 Billion To Back Six R&D Programmes Across Malaria, Tuberculosis And Neglected Tropical Diseases
The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projec...
February 04, 2026 | News
SK Bioscience Launches Global Phase1/2 Trial In Australia For Universal Sarbecovirus Vaccine GBP511
SK bioscience announced the initiation of a global Phase 1/2 clinical trial in Australia for GBP511, a vaccine candidate targeting the sarbecovirus subgenu...
January 30, 2026 | News
SK Bioscience Advances Zaire Ebolavirus Vaccine Development With CEPI Backed Global Collaboration
SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition for Epidemi...
January 23, 2026 | News
AIM Vaccine Advances High Efficiency Diploid Rabies Vaccine Into Final Clinical Stage
AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficie...
January 19, 2026 | News
Hyundai BioScience Sets Out A Pre Emptive Antiviral Play To Tackle Multiple Viruses With One Drug
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks...
January 19, 2026 | News
Antengene Showcases Next Phase Of Global Innovation At J P Morgan Healthcare Conference
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...
January 19, 2026 | News
Aptar Powers Intranasal Covid Vaccine Trial With LuerVax And Spray Divider Delivery Systems
AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its inno...
January 15, 2026 | News
Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch
- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...
January 13, 2026 | News
Sanofi To Acquire Dynavax For $15.50 Per Share In $2.2 Billion All Cash Deal
Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 Sanofi announced that it has entered into...
January 02, 2026 | News
Intas Pharmaceuticals Limited Secures Exclusive Needle Free Injection Technology For IVF And Gynecology In India
Intas Pharmaceuticals Limited (“Intas”), a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...
December 30, 2025 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
